These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, Rossi A, Pini S, Vita A, Cassano P, Stratta P, Severino G, Del Zompo M. Neuropsychobiology; 2005; 52(2):83-9. PubMed ID: 16037677 [Abstract] [Full Text] [Related]
43. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. Genes Brain Behav; 2011 Apr; 10(3):316-24. PubMed ID: 21255265 [Abstract] [Full Text] [Related]
44. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia. Bosia M, Bechi M, Marino E, Anselmetti S, Poletti S, Cocchi F, Smeraldi E, Cavallaro R. Neurosci Lett; 2007 May 07; 417(3):271-4. PubMed ID: 17383818 [Abstract] [Full Text] [Related]
47. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, Schulze TG, Reshef A, Blanaru M, Gathas S, Goichman R, Rietschel M, Dobrusin M, Bachner-Melman R, Nemanov L, Belmaker RH, Maier W, Ebstein RP. Am J Med Genet B Neuropsychiatr Genet; 2003 May 15; 119B(1):35-9. PubMed ID: 12707935 [Abstract] [Full Text] [Related]
50. Association between genes, stressful childhood events and processing bias in depression vulnerable individuals. Vrijsen JN, van Oostrom I, Arias-Vásquez A, Franke B, Becker ES, Speckens A. Genes Brain Behav; 2014 Jun 15; 13(5):508-16. PubMed ID: 24589356 [Abstract] [Full Text] [Related]
51. Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia? Chang HA, Lu RB, Shy MJ, Chang CC, Lee MS, Huang SY. J Neuropsychiatry Clin Neurosci; 2009 Jun 15; 21(1):30-7. PubMed ID: 19359449 [Abstract] [Full Text] [Related]
52. Association between the Val66Met (rs6265) polymorphism of the brain-derived neurotrophic factor (BDNF) gene, BDNF protein level in the blood and the risk of developing early‑onset Parkinson's disease. Przybylska I, Marusiak J, Toczyłowska B, Stępień A, Brodacki B, Langfort J, Chalimoniuk M. Acta Neurobiol Exp (Wars); 2024 Oct 11; 84(3):296-308. PubMed ID: 39392027 [Abstract] [Full Text] [Related]
53. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Albayrak Y, Ünsal C, Beyazyüz M, Ünal A, Kuloğlu M. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():144-9. PubMed ID: 23657077 [Abstract] [Full Text] [Related]
54. Cannabis use, COMT, BDNF and age at first-episode psychosis. Mané A, Bergé D, Penzol MJ, Parellada M, Bioque M, Lobo A, González-Pinto A, Corripio I, Cabrera B, Sánchez-Torres AM, Saiz-Ruiz J, Bernardo M, PEPs GroupCentro de Investigación en Red de Salud Mental (CIBERSAM), Spain.. Psychiatry Res; 2017 Apr 01; 250():38-43. PubMed ID: 28142064 [Abstract] [Full Text] [Related]
55. Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? Shaikh M, Hall MH, Schulze K, Dutt A, Walshe M, Williams I, Constante M, Picchioni M, Toulopoulou T, Collier D, Rijsdijk F, Powell J, Arranz M, Murray RM, Bramon E. Psychol Med; 2011 Feb 01; 41(2):263-76. PubMed ID: 20102668 [Abstract] [Full Text] [Related]
56. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T. Neurosci Lett; 2006 Jun 19; 401(1-2):1-5. PubMed ID: 16533563 [Abstract] [Full Text] [Related]
57. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli. Lo Bianco L, Blasi G, Taurisano P, Di Giorgio A, Ferrante F, Ursini G, Fazio L, Gelao B, Romano R, Papazacharias A, Caforio G, Sinibaldi L, Popolizio T, Bellantuono C, Bertolino A. Psychol Med; 2013 Feb 19; 43(2):279-92. PubMed ID: 22617427 [Abstract] [Full Text] [Related]
58. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Sullens A, Yolken RH. Schizophr Res; 2007 Nov 19; 96(1-3):87-92. PubMed ID: 17601704 [Abstract] [Full Text] [Related]
59. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. Costas J, Sanjuán J, Ramos-Ríos R, Paz E, Agra S, Ivorra JL, Páramo M, Brenlla J, Arrojo M. J Psychiatr Res; 2011 Jan 19; 45(1):7-14. PubMed ID: 20488458 [Abstract] [Full Text] [Related]
60. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. Tang X, Zhou C, Gao J, Duan W, Yu M, Xiao W, Zhang X, Dong H, Wang X, Zhang X. BMC Psychiatry; 2019 Aug 16; 19(1):254. PubMed ID: 31420036 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]